COGT (cogentbio.com) Earnings per share growth this year

Official company branding of Cogent Corp (COGT)

Cogent Biosciences (COGT) maintains its status as a reputable player in precision oncology amid cautious investor optimism. Comparable earnings per share growth relative to last year demonstrates price action where -7.10 determines the current magnitude of the metric. The business's success relies on unique patents targeting rare blood mutations, and its development remains independent of economic cycles, basing itself exclusively on regulatory approvals.

COGT (cogentbio.com) Earnings per share growth in current year history from 07/04/2022 to 11/16/2026

Financial and market metric breakdowns for cogentbio.com (COGT)

- stock value and consensus price forecast:
Basic company analysis:Cogent Corp (COGT)
Manufactured products of Cogent Biosciences

This indicator measures the year-over-year dynamics of net earnings per share, allowing investors to track the actual rate of capital growth without the delays of quarterly reporting. By analyzing the distribution of the annual change in earnings per share, one can assess the financial stability of Cogent Biosciences (COGT) prior to its entry into the ultra-high-margin targeted therapy market, where patent protection will ensure long-term patient dependency and high profitability.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year UTHR (United Therapeutics Corporation)|BMRN (BioMarin Pharmaceutical Inc.) - Earnings per share increase in current year|Earnings per share growth in current year BridgeBio BBIO|Earnings per share increase in current year BGM|Xeris Biopharma - Earnings growth in current year|Earnings per share increase in current year KROS (Keros Therapeutics)|ARCT: Earnings growth in current year|Eton Pharmaceuticals Inc (ETON) - Earnings growth in current year|Earnings per share growth in current year Kamada Corp|FULC: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics, Inc. (ABEO)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc